8110 J . Org. Chem., Vol. 66, No. 24, 2001
Shen et al.
55.5, 51.4, 50.6, 38.5, 21.4, 18.4, -33.3. IR (neat, cm-1): 1719
(s). MS (EI, 75 eV) m/e (relative intensities, %): 613 (M+, 11),
585 (96), 557 (92), 529 (44). Anal. Calcd for WC23H24NO6S: C,
44.08; H, 3.86; N, 2.24. Found: C, 43.78; H, 3.77; N, 2.20.
(6) Cycliza tion of P r op a r gyltu n gsten Com p ou n d 6a .
To a CH2Cl2 solution (10 mL) of compound 6a (0.30 g, 0.48
mmol) was added BF3‚Et2O (0.12 mmol) at -40 °C, and the
solution was slowly warmed to 23 °C in a period of 6 h. To
this dark yellow suspension was added a saturated NaHCO3
solution, and the organic layer was extracted with diethyl
ether, dried over MgSO4, concentrated, and chromatographed
through a silica column to afford compound 6a as a yellow solid
7a (201 mg, 0.33 mmol, 67%). IR (neat, cm-1): υ(CO) 2001
(10) Syn th esis of (2R,3R)-2-[(4-Br om o-2-bu tyn yl(2S,3R)-
3-m eth yl-oxir a n -2-yl Eth er (38). The chiral ketone derived
from fructose was prepared according to the method in the
literature. A buffer solution (pH 9-10) was prepared from
Na2B4O7‚10H2O (1.907 g), Na2EDTA (1 mL, 0.1 M), and water
(99 mL). This buffer solution (20 mL) was added with CH3CN
(30 mL), propargyl bromide 36 (0.60 g, 2.96 mmol), chiral
fructose-derived ketone (0.46 g, 0.60 mmol), and Bu4NHSO4
(0.030 g). To this mixture were added an aqueous K2CO3
solution (2.00 g, 13 mL of water) and a Na2EDTA solution (4
× 10-4 M, 18 mL) of oxone (2.52 g) in a period of 2 h. The
mixtures were stirred at 0 °C for an additional 3 h before
quenching with pentane (50 mL) and water (30 mL). The
organic layer was extracted with pentane, dried over MgSO4,
and chromatographed through a Et3N-pretreated silica column
to afford 38 (0.52 g, 2.40 mmol, 81%) as a colorless oil. [R]D
-63.7° (c 0.45, CHCl3). IR (Nujol, cm-1): υ(CtC) 2177 (m).
1H NMR (400 MHz, CDCl3): δ 4.23 (2H, m), 3.89 (2H, t, J )
1
(s), 1903 (s). H NMR (400 MHz, CDCl3): δ 7.67 (2H, d, J )
8.4 Hz), 7.27 (2H, d, J ) 8.4 Hz), 5.46 (5H, s), 3.94 (2H, ABq,
J ) 15.4 Hz), 3.78 (1H, d, J ) 14.4 Hz), 3.69 (1H, d, J ) 10.4
Hz), 3.49 (1H, d, J ) 14.4 Hz), 3.26 (1H, d, J ) 8.8 Hz), 3.09
(1H, d, J ) 10.4 Hz), 2.56 (1H, d, J ) 8.8 Hz), 2.38 (3H, s),
1.08 (3H, s). 13C NMR (100 MHz, CDCl3): δ 146.1, 143.3, 133.1,
129.6, 127.5, 115.0, 91.2, 77.8, 72.0, 57.2, 54.5, 44.3, 22.4, 21.4.
MS (EI, 75 eV) m/e (relative intensities, %): 613 (M+, 13), 585
(86), 557 (92), 529 (26). Anal. Calcd for WC23H25NO6S: C,
44.08; H, 3.86; N, 2.24. Found: C, 43.97; H, 3.97; N, 2.30.
(7) Syn th esis of 3a -Meth yl-2-(tolu en e-4-su lfon yl)-1,2,3,
3a ,4,6-h exa h yd r op yr a n o[3,4-c]p yr r ole-7-ca r boxylic Acid
Ben zyl Ester (8a ). To a CH2Cl2 solution (2.0 mL) of compound
7a (0.154 g, 0.24 mmol) was added benzyl alcohol (0.48 mmol)
and I2 (94 mg, 0.38 mmol) at -78 °C, and the mixture was
stirred for 30 min and slowly warmed to 23 °C. To this solution
was added water (3.5 mL) containing Na2S2O3 (50 mg), and
the mixture was extracted with CH2Cl2, dried over MgSO4,
and chromatographed on a small silica column to afford the
ester 8a (88 mg, 0.20 mmol, 82%). IR (neat, cm-1): υ(CO) 1714
(s). 1H NMR (400 MHz, CDCl3): δ 7.65 (2H, d, J ) 4.0 Hz),
7.29-7.42 (5H, m), 7.29 (2H, d, J ) 4.0 Hz), 5.15 (2H, ABq, J
) 6.0 Hz), 4.36 (2H, ABq, J ) 7.2 Hz), 4.14 (2H, ABq, J ) 4.0
Hz), 3.77 (1H, d, J ) 10.0 Hz), 3.43 (1H, d, J ) 8.8 Hz), 3.07
(1H, d, J ) 10.0 Hz), 2.54 (1H, d, J ) 8.8 Hz), 2.44 (3H, s),
1.27 (3H, s). 13C NMR (100 MHz, CDCl3): δ 164.0, 153.3, 143.7,
135.5, 133.0, 129.8, 128.7, 128.5, 128.4, 127.7, 120.1, 70.7, 66.4,
64.0, 55.8, 51.1, 42.3, 23.1, 21. HRMS calcd for C24H27NO5S,
427.1453; found, 427.1455.
(8) Syn th esis of 3a -Meth yl-2-(tolu en e-4-su lfon yl)-1,2,3,
3a ,4,6-h exa h yd r op yr a n o[3,4-c]-p yr r ole (8b). To a CH3CN
solution (5 mL) of compound 7a (200 mg, 0.32 mmol) was
added trimethylamine oxide (97 mg, 1.28 mmol) at 0 °C, and
the mixtures were stirred for 12 h. To this solution was added
water (3 mL), and the CH2Cl2 layer was separated, dried over
MgSO4, concentrated, and eluted through a silica column to
afford compound 8b as a colorless solid (73 mg, 0.24 mmol,
78%). IR (neat, cm-1): υ(CO) 1704 (s), 1672 (w). 1H NMR (400
MHz, CDCl3): δ 7.70 (2H, d, J ) 8.0 Hz), 7.31 (2H, d, J ) 8.0
Hz), 5.40 (1H, s), 4.11 (1H, m), 4.00 (2H, m), 3.72-3.95 (2H,
m), 3.31 (1H, d, J ) 9.2 Hz), 3.09 (1H, d, J ) 10.4 Hz), 2.73
(1H, d, J ) 9.2 Hz), 2.42 (3H, s), 1.06 (3H, s). 13C NMR (100
MHz, CDCl3): δ 143.5, 134.7, 133.9, 129.6, 127.5, 118.4, 67.2,
65.4, 55.6, 51.3, 43.7, 23.2, 21.4. HRMS calcd for C15H19NO3S,
293.1085; found, 293.1083.
2.0 Hz), 3.68 (1H, dd, J 1 ) 11.2, 3.2 Hz), 3.44 (1H, dd, J 1
)
11.2, 5.6 Hz), 2.81-2.89 (2H, m), 1.26 (3H, d, J ) 7.6 Hz). 13C
NMR (100 MHz, CDCl3): δ 82.4, 81.6, 69.9, 58.5, 57.3, 52.0,
17.1, 14.0. HRMS calcd for C8H11BrO2, 219.9942; found,
219.9948.
(9) Syn th esis of Ch ir a l P r op a r gyltu n gsten Com p ou n d
40. To a THF solution of chiral bromopropargyl epoxide 38
(0.50 g, 2.28 mmol) was added NaCpW(CO)3 (2.30 mmol), and
the mixture was stirred for 8 h. The solution was concentrated
and eluted through
a silica column to afford the chiral
propargyltungsten compound 40 as a yellow solid (0.79 g, 1.66
mmol, 73%). [R]25D -34.2 (c 2.5, CHCl3). IR (neat, cm-1): υ(CO)
2001 (s), 1903 (s), 1713 (s). 1H NMR (400 MHz, CDCl3): δ 5.42
(5H, s), 4.13 (2H, d, J ) 3.0 Hz), 3.68 (1H, dt, J ) 11.2, 2.8
Hz), 3.38-3.46 (1H, m), 2.78-2.86 (2H, m), 1.89 (2H, t, J )
3.0 Hz), 1.22 (3H, d, J ) 7.8 Hz). 13C NMR (100 MHz, CDCl3):
δ 228.7, 216.5, 96.3, 92.4, 75.3, 69.1, 59.1, 57.4, 51.8, 17.1,
-33.1. MS (EI, 75 eV) m/e (relative intensities, %): 472 (M+,
10), 444 (98), 416 (90), 388 (53). Anal. Calcd for WC16H16O5:
C, 40.59; H, 3.62. Found: C, 40.77; H, 3.78.
(10) Cycliza tion of Ch ir a l P r op a r gyltu n gsten Ep oxid e
40. Following the preceding procedure, the reaction of BF3‚Et2O
(0.16 g, 1.33 mmol) and chiral propargyltungsten epoxide 40
(0.70 g, 1.48 mmol) in CH2Cl2 afforded the chiral cycloadduct
42 (0.47 g, 0.99 mmol, 67%). [R]25 +67.9 (c 0.8, CHCl3). IR
D
(neat, cm-1): υ(CO) 2000 (s), 1913 (s). 1H NMR (400 MHz,
CDCl3): δ 5.54 (5H, s), 3.33 (1H, d, J ) 3.6 Hz), 3.96-4.16
(4H, m), 3.15-3.24 (2H, m), 2.59 (1H, dt, J ) 12.3, 1.6 Hz),
1.16 (3H, d, J ) 2.8 Hz). 13C NMR (100 MHz, CDCl3): δ 146.0,
111.9, 91.0, 78.7, 73.7, 72.0, 70.4, 49.8, 20.7. MS (EI, 75 eV)
m/e (relative intensities, %): 472 (M+, 10), 444 (91), 416 (88),
388 (66). Anal. Calcd for WC16H16O5: C, 40.62; H, 3.52.
Found: C, 40.44; H, 3.77.
(9) Syn th esis of 3a -Meth yl-2-(tolu en e-4-su lfon yl)-1,2,3,
3a ,4,6-h exa h yd r op yr a n o[3,4-c]-p yr r ol-7-on e (8c). To a
CH2Cl2 solution (5.0 mL) of compound 7a (6 mg, 0.090 mmol)
was added m-CPBA (71 mg, 0.19 mmol) at -78 °C, and the
solution was warmed to 23 °C for 12 h. The solution was
filtered over a short basic alumina bed, concentrated, and
eluted through a silica column to afford compounds 8b and
8c in 47% and 41% yields, respectively. Spectral data for 8c,
IR (neat, cm-1): υ(CO) 1712 (s), 1683 (w). 1H NMR (400 MHz,
CDCl3): δ 7.68 (2H, d, J ) 8.0 Hz), 7.31 (2H, d, J ) 8.0 Hz),
3.90 (2H, ABq, J ) 9.6 Hz), 3.73 (1H, dd, J ) 10.6, 3.9 Hz),
3.58 (2H, ABq, J ) 5.6 Hz), 3.47 (1H, dd, J ) 10.6, 8.2 Hz),
3.12 (2H, ABq, J ) 9.6 Hz), 2.47 (1H, dd, J ) 8.2, 3.9 Hz),
2.47 (1H, dd, J ) 10.6, 3.9 Hz), 2.42 (3H, s). 13C NMR (100
MHz, CDCl3): δ 210.2, 143.5, 134.7, 133.2, 129.4, 127.5, 81.0,
77.1, 53.5, 48.9, 36.3, 31.4, 15.1. HRMS calcd for C15H19NO4S,
309.1034; found, 309.1044.
(11) Syn th esis of Ben zyl(7R,7a S)-7-m eth yl-1,3,5,6,7,7a -
h exa h yd r o-4-isoben zo-fu r a n ca r boxyla te (44). This com-
pound was prepared similarly from a CH2Cl2 solution of I2 (140
mg, 0.41 mmol), benzyl alcohol (60 mg, 0.55 mmol), and